RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Personal Protective Equipment for Healthcare Workers during the COVID-19 Pandemic

      한글로보기

      https://www.riss.kr/link?id=A106931623

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The coronavirus disease (COVID-19) pandemic has posed a challenge for healthcare systems, and healthcare workers (HCWs) are at high risk of exposure. Protecting HCWs is of paramount importance to maintain continuous patient care and keep healthcare systems functioning. Used alongside administrative and engineering control measures, personal protective equipment (PPE) is the last line of defense and the core component of protection. Current data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mainly transmitted through respiratory droplets and close contact. Airborne transmission may occur during aerosol-generating procedures. However, the modes of transmission still remain uncertain, especially regarding the possibility of airborne transmission when aerosol-generating procedures are not performed. Thus, there are some inconsistencies in the respiratory protective equipment recommended by international and national organizations. In Korea, there have been several modifications to PPE recommendations offering options in choosing PPE for respiratory and body protection, which confuses HCWs; they are often unsure what to wear and when to wear it. The choice of PPE is based on the risk of exposure and possible modes of transmission. The level of protection provided by PPE differs based on standards and test methods. Thus, understanding them is the key in selecting the proper PPE. This article reviews evidence on the mode of SARS-CoV-2 transmission, compares the current PPE recommendations of the World Health Organization with those in Korea, and discusses standard requirements and the proper selection of PPE.
      번역하기

      The coronavirus disease (COVID-19) pandemic has posed a challenge for healthcare systems, and healthcare workers (HCWs) are at high risk of exposure. Protecting HCWs is of paramount importance to maintain continuous patient care and keep healthcare sy...

      The coronavirus disease (COVID-19) pandemic has posed a challenge for healthcare systems, and healthcare workers (HCWs) are at high risk of exposure. Protecting HCWs is of paramount importance to maintain continuous patient care and keep healthcare systems functioning. Used alongside administrative and engineering control measures, personal protective equipment (PPE) is the last line of defense and the core component of protection. Current data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mainly transmitted through respiratory droplets and close contact. Airborne transmission may occur during aerosol-generating procedures. However, the modes of transmission still remain uncertain, especially regarding the possibility of airborne transmission when aerosol-generating procedures are not performed. Thus, there are some inconsistencies in the respiratory protective equipment recommended by international and national organizations. In Korea, there have been several modifications to PPE recommendations offering options in choosing PPE for respiratory and body protection, which confuses HCWs; they are often unsure what to wear and when to wear it. The choice of PPE is based on the risk of exposure and possible modes of transmission. The level of protection provided by PPE differs based on standards and test methods. Thus, understanding them is the key in selecting the proper PPE. This article reviews evidence on the mode of SARS-CoV-2 transmission, compares the current PPE recommendations of the World Health Organization with those in Korea, and discusses standard requirements and the proper selection of PPE.

      더보기

      참고문헌 (Reference)

      1 한돈희, "보건의료종사자의 안면부여과식 마스크의 사용과 밀착도검사의 중요성" 한국산업보건학회 25 (25): 245-253, 2015

      2 World Health Organization (WHO), "WHO coronavirus disease (COVID-19) dashboard (2020/6/6)"

      3 World Health Organization (WHO), "WHO "SAVE LIVES: Clean Your Hands" Campaign and WHO COVID-19 Response: WHO webiar series"

      4 Anfinrud P, "Visualizing speech-generated oral fluid droplets with laser light scattering" 382 : 2061-2063, 2020

      5 Lindsley WG, "Viable influenza A virus in airborne particles from human coughs" 12 : 107-113, 2015

      6 Hall S, "Use of ultraviolet-fluorescence-based simulation in evaluation of personal protective equipment worn for first assessment and care of a patient with suspected high-consequence infectious disease" 99 : 218-228, 2018

      7 Center for Health Protection, "Use mask properly"

      8 Canova V, "Transmission risk of SARS-CoV-2 to healthcare workers-observational results of a primary care hospital contact tracing" 150 : w20257-, 2020

      9 Otter JA, "Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings : the possible role of dry surface contamination" 92 : 235-250, 2016

      10 Santarpia JL, "Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center"

      1 한돈희, "보건의료종사자의 안면부여과식 마스크의 사용과 밀착도검사의 중요성" 한국산업보건학회 25 (25): 245-253, 2015

      2 World Health Organization (WHO), "WHO coronavirus disease (COVID-19) dashboard (2020/6/6)"

      3 World Health Organization (WHO), "WHO "SAVE LIVES: Clean Your Hands" Campaign and WHO COVID-19 Response: WHO webiar series"

      4 Anfinrud P, "Visualizing speech-generated oral fluid droplets with laser light scattering" 382 : 2061-2063, 2020

      5 Lindsley WG, "Viable influenza A virus in airborne particles from human coughs" 12 : 107-113, 2015

      6 Hall S, "Use of ultraviolet-fluorescence-based simulation in evaluation of personal protective equipment worn for first assessment and care of a patient with suspected high-consequence infectious disease" 99 : 218-228, 2018

      7 Center for Health Protection, "Use mask properly"

      8 Canova V, "Transmission risk of SARS-CoV-2 to healthcare workers-observational results of a primary care hospital contact tracing" 150 : w20257-, 2020

      9 Otter JA, "Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings : the possible role of dry surface contamination" 92 : 235-250, 2016

      10 Santarpia JL, "Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center"

      11 Roberts V, "To PAPR or not to PAPR?" 50 : 87-90, 2014

      12 Insitute of Medicine(IOM), "The use and effectiveness of powered air purifying respirators in health care: workshop summary" National Academies Press (US) 2015

      13 Gralton J, "The role of particle size in aerosolised pathogen transmission : a review" 62 : 1-13, 2011

      14 World Health Organization (WHO), "The WHO guidelines Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care"

      15 Centers for Disease Control and Prevention (CDC), "The National Personal Protective Technology Laboratory (NPPTL). Considerations for selecting protective clothing used in healthcare for protection against microorganisms in blood and body fluids"

      16 Centers for Disease Control and Prevention (CDC), "The National Institute for Occupational Safety and Health (NIOSH). 42 CFR part 84 respiratory protective devices"

      17 3M, "Technical bulletin: Comparison of FFP2, KN95, and N95 and other filtering facepiece respirator Classes"

      18 Alhazzani W, "Surviving sepsis campaign : guidelines on the management of critically ill adults with Coronavirus Disease 2019(COVID-19)" 46 : 854-887, 2020

      19 Food and Drug Administration (FDA), "Surgical masks - Premarket notification [510(k)] submissions: guidance for industry and FDA staff"

      20 Hrncír E, "Surface tension of blood" 46 : 319-321, 1997

      21 American Society for Testing and Materials (ASTM) International, "Standard Specification for Performance of Materials Used in Medical Face Masks"

      22 Chin AWH, "Stability of SARS-CoV-2 in different environmental conditions" 2020

      23 Government of Canada, "Specifications for COVID-19 Products"

      24 Liu L, "Short-range airborne transmission of expiratory droplets between two people" 27 : 452-462, 2017

      25 Suen LKP, "Self-contamination during doffing of personal protective equipment by healthcare workers to prevent Ebola transmission" 7 : 157-, 2018

      26 European CenterDisease Control and Prevention (ECDC), "Safe use of personal protective equipment in the treatment of infectious diseases of high consequence"

      27 Wong SCY, "Risk of nosocomial transmission of coronavirus disease 2019 : an experience in a general ward setting in Hong Kong" 105 : 119-127, 2020

      28 Lee MC, "Respirator-fit testing : does it ensure the protection of healthcare workers against respirable particles carrying pathogens?" 29 : 11491156-, 2008

      29 Radonovich LJ Jr, "ResPECT investigators. N95 Respirators vs medical masks for preventing influenza among health care personnel : a randomized clinical trial" 322 : 824-833, 2019

      30 Tellier R, "Recognition of aerosol transmission of infectious agents : a commentary" 19 : 101-, 2019

      31 World Health Organization (WHO), "Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages: interim guidance"

      32 National Academies of Sciences, Engineering, and Medicine, "Rapid Expert Consultations on the COVID-19 Pandemic: March 14, 2020-April 8, 2020" National Academis Press 2020

      33 Instutute of Medicine(IOM), "Preventing transmission of pandemic influenza and other viral respiratory diseases: personal protective equipment for healthcare personnel" National Academies Press 2011

      34 Korea Center for Disease Control and Prevention (KCDC), "Press release on full body protective clothing"

      35 World Health Organization (WHO), "Personal protective equipment for use in a filovirus disease outbreak: rapid advice guideline"

      36 Phan LT, "Personal protective equipment doffing practices of healthcare workers" 16 : 575-581, 2019

      37 Gao S, "Performance of an improperly sized and stretched-out loose-fitting powered air-purifying respirator : Manikin-based study" 13 : 169-176, 2016

      38 United States Department of Labor, "Occupational Safety and Health Act. 29CFR 1910.134. Respiratory protection"

      39 Judson SD, "Nosocomial transmission of emerging viruses via aerosol-generating medical procedures" 11 : 940-, 2019

      40 Centers for Disease Control and Prevention (CDC), "NPPTL respirator assessments to support the COVID19 response"

      41 World Health Organization (WHO), "Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendationsscientific brief"

      42 Korea Center for Disease Control and Prevention (KCDC), "Ministry of Health and Welfare. Infection prevention and control for novel coronavirus infection"

      43 Bartoszko JJ, "Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers : a systematic review and meta-analysis of randomized trials" 14 : 365-373, 2020

      44 Lindsley WG, "Measurements of airborne influenza virus in aerosol particles from human coughs" 5 : e15100-, 2010

      45 Centers for Disease Control and Prevention (CDC), "Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings"

      46 Centers for Disease Control and Prevention (CDC), "Interim infection prevention and control guidance for dental settings during the COVID-19 response"

      47 Australian Government Department of Health, "Interim advice on non-inpatient care of persons with suspected or confirmed Coronavirus disease (COVID19), including use of personal protective equipment (PPE)"

      48 Yan J, "Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community" 115 : 1081-1086, 2018

      49 Infectious Disease Society of America (IDSA), "Infectious Diseases Society of America guidelines on infection prevention for health care personnel caring for patients with suspected or known COVID-19"

      50 Government of Canada, "Infection prevention and control for COVID-19: second interim guidance for acute healthcare settings"

      51 European Center for Disease Control and Prevention (ECDC), "Infection prevention and control for COVID-19 in healthcare settings – 3rd update"

      52 Korea Center for Disease Control and Prevention (KCDC), "Infection prevention and control for COVID-19 in healthcare facilities"

      53 World Health Organization (WHO), "Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance"

      54 World Health Organization (WHO), "Infection prevention and control during health care when COVID-19 is suspected: interim guidance"

      55 McMahon E, "Implementing fit testing for N95 filtering facepiece respirators : practical information from a large cohort of hospital workers" 36 : 298-300, 2008

      56 Bischoff WE, "How well do N95 respirators protect healthcare providers against aerosolized influenza virus?" 1-3, 2018

      57 Xie X, "How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve" 17 : 211-225, 2007

      58 Occupational Safety and Health Administration (OSHA), "Hospital respiratory protection program toolkit: resources for respirator program administrators"

      59 National Institute of Food and Drug Safety Evaluation (NIFDS), "Guidelines for standards of health masks (civil complaints guide)" Ministry of Food and Drug Safety

      60 National Institute of Food and Drug Safety Evaluation (NIFDS), "Guideline on establishment of test item in preparation of standards and analytical methods of quasi-drugs (August 2016)" Ministry of Food and Drug Safety

      61 Korea Occupational Safety and Health Admisnitration (KOSHA), "Guide to respiratory protection"

      62 Coia JE, "Guidance on the use of respiratory and facial protection equipment" 85 : 170-182, 2013

      63 Australian Government Department of Health, "Guidance on the use of personal protective equipment (PPE) in hospitals during the COVID-19 outbreak"

      64 Koo Bo Kyung, "Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening" 대한감염학회 52 (52): 219-221, 2020

      65 Tang JW, "Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises" 64 : 100-114, 2006

      66 Cheng VCC, "Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019(COVID-19)due to SARS-CoV-2 in Hong Kong" 41 : 493-498, 2020

      67 Long Y, "Effectiveness of N95 respirators versus surgical masks against influenza : a systematic review and meta-analysis" 13 : 93-101, 2020

      68 Wong TKS, "Effective personal protective clothing for health care workers attending patients with severe acute respiratory syndrome" 32 : 90-96, 2004

      69 World Health Organization(WHO), "Ebola virus disease: operational support and logistics: disease commodity packages"

      70 Lindsley WG, "Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic" 50 : 693-698, 2010

      71 Carlos Rubio-Romero J, "Disposable masks : Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic" 129 : 104830-, 2020

      72 Noti JD, "Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room" 54 : 1569-1577, 2012

      73 CDC, "Covid-19 Response Team. Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020" 69 : 477-481, 2020

      74 Centers for Disease Control and Prevention (CDC), "Coronavirus disease 2019 (COVID-19): N95 respirators"

      75 Centers for Disease Control and Prevention (CDC), "Coronavirus disease 2019 (COVID-19). Powered air purifying respirators: For healthcare practitioners (HCP)"

      76 Centers for Disease Control and Prevention (CDC), "Coronavirus disease 2019 (COVID-19). Elastomeric respirators: Conventional, contingency, and crisis strategies"

      77 European Center for Disease Control and Prevention (ECDC), "Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – ninth update"

      78 Zhang JC, "Controversies in respiratory protective equipment selection and use during COVID-19" 15 : 292-294, 2020

      79 Kim H, "Comparison of fit factors among healthcare providers working in the Emergency Department Center before and after training with three types of N95 and higher filter respirators" 98 : e14250-, 2019

      80 Jung H, "Comparison of filtration efficiency and pressure drop in anti-yellow sand masks, quarantine masks, medical masks, general masks, and handkerchiefs" 14 : 991-1002, 2014

      81 Public Health England (PHE), "COVID-19: Guidance for infection prevention and control in healthcare settings. Version 3.0"

      82 World Health Organization (WHO), "COVID-19 v4: operational support and logistics: disease commodity packages"

      83 Chu DK, "COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis" 2020

      84 United States Department of Labor, "Assigned protection factors: for the revised respirtory protection standard"

      85 Roy CJ, "Airborne transmission of communicable infection--the elusive pathway" 350 : 1710-1712, 2004

      86 Seto WH, "Airborne transmission and precautions : facts and myths" 89 : 225-228, 2015

      87 Bahl P, "Airborne or droplet precautions for health workers treating COVID-19?" 2020

      88 Ong SWX, "Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)from asymptomatic patient" 323 : 1610-1612, 2020

      89 Tran K, "Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers : a systematic review" 7 : e35797-, 2012

      90 Guo ZD, "Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020" 26 : 1583-1591, 2020

      91 Liu Y, "Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals" 2020

      92 American National Standard, "ANSI/AAMI:PB70:2012 liquid barrier performance and classification of protective apparel and drapes intended for use in healthcare facilities"

      93 Association for the Advancement of Medical Instrumentation (AAMI), "AAMI TIR11:2005/(R)2015: Selection and use of protective apparel and surgical drapes in health care facilities"

      94 Han DH, "A study on the current status and system improvement of the respiratory protection test" Korea Occupational Safety and Health Agency 2017

      95 Lofgren DJ, "A must for NIOSH : certify fit performance of the half mask particulate respirator" 9 : D191-5, 2012

      96 Faridi S, "A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran" 725 : 138401-, 2020

      97 Siegel JD, "2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings"

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-02-25 학술지명변경 한글명 : 감염과화학요법 -> Infection and Chemotherapy
      외국어명 : Infection and Chemotherapy -> 미등록
      KCI등재후보
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-08-25 학술지명변경 외국어명 : 미등록 -> Infection and Chemotherapy KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2008-01-01 평가 등재후보 탈락 (등재후보1차)
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-05-27 학술지등록 한글명 : 감염과화학요법
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.24 0.24 0.24
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.2 0.2 0.46 0.29
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼